These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7287210)

  • 1. Monoclonal antibody against a naturally occurring rat mammary carcinoma.
    Gunn B; Embleton MJ; Middle JG; Baldwin RW
    Int J Cancer; 1980 Sep; 26(3):325-30. PubMed ID: 7287210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumour antibodies induced by rat embryo cells and spontaneous mammary carcinoma cells treated with 3-methylcholanthrene.
    Reeve JG; Embleton MJ; Baldwin RW
    Br J Cancer; 1981 Jun; 43(6):809-16. PubMed ID: 7018549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas.
    North SM; Steck PA; Nicolson GL
    Cancer Res; 1986 Dec; 46(12 Pt 1):6393-9. PubMed ID: 3779654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies of the metastatic potential of three transplantable rat mammary carcinomas of spontaneous origin.
    Willmott N; Austin EB; Baldwin RW
    Br J Exp Pathol; 1979 Oct; 60(5):499-506. PubMed ID: 518819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies against antigens displayed on a progressively growing mammary tumor.
    Tax A; Manson LA
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):529-33. PubMed ID: 6264447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCG treatment of transplanted rat tumours of spontaneous origin.
    Pimm MV; Cook AJ; Hopper DG; Dickinson AM; Baldwin RW
    Int J Cancer; 1978 Oct; 22(4):426-32. PubMed ID: 700898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of serum antibodies induced in syngeneic rats after administration of monoclonal antibody MT10:21.
    North SM; Gurin JL
    Immunology; 1989 Jan; 66(1):26-31. PubMed ID: 15493258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour rejection in rats sensitized to embryonic tissue. I. Rejection of tumour cells implanted s.c. and detection of cytotoxic lymphoid cells.
    Shah LP; Rees RC; Baldwin RW
    Br J Cancer; 1976 Jun; 33(6):577-83. PubMed ID: 181040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated cytotoxicity to chemically-induced rat tumours.
    Zöller M; Price MR; Baldwin RW
    Int J Cancer; 1975 Oct; 16(4):593-606. PubMed ID: 170224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a murine monoclonal antibody to normal mammary epithelium using mice rendered immune-tolerant to malignant mammary epithelium.
    Imam SA; Esteban EF; Young LL; Taylor CR
    J Histochem Cytochem; 1994 May; 42(5):585-91. PubMed ID: 7512585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observations on the increasing malignancy of tumours on prolonged growth: the influence of immunological changes in the host.
    Rees JA; Symes MO
    Br J Cancer; 1971 Mar; 25(1):121-9. PubMed ID: 4397225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of a syngeneic monoclonal antibody to a rat mammary tumor metastasis-associated mucin-like cell-surface antigen (gp580).
    North SM; Steck PA; Spohn WH; Nicolson GL
    Int J Cancer; 1988 Oct; 42(4):607-14. PubMed ID: 3170031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of two anti-tumour monoclonal antibody preparations.
    Price MR; Dennick RG; Fang CY; Hannant D; Embleton MJ; Gunn B; Baldwin RW
    Arch Geschwulstforsch; 1981; 51(4):302-9. PubMed ID: 6947720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the immunologic specificity of the macrophage-electrophoresis mobility test in mice with syngeneic and allogeneic transplants of mammary carcinoma].
    Kotzsch M; Irmscher J; Fischer R; Heidl G; Müller M
    Acta Biol Med Ger; 1976; 35(12):1749-53. PubMed ID: 69378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C. parvum treatment of transplanted rat tumours of spontaneous origin.
    Willmott N; Pimm MV; Baldwin RW
    Int J Cancer; 1979 Sep; 24(3):323-8. PubMed ID: 385514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to estrophilin: probes for the study of estrogen receptors.
    Greene GL; Fitch FW; Jensen EV
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):157-61. PubMed ID: 6928610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of naturally occurring anti-tissue antibodies during growth and after removal of tumours.
    Chandradasa KD; Elson CJ
    Gan; 1979 Jun; 70(3):261-6. PubMed ID: 467891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour-related antigen specificities associated with 3-methylcholanthrene-treated rat embryo cells.
    Embleton MJ; Baldwin RW
    Int J Cancer; 1979 Jun; 23(6):840-5. PubMed ID: 89103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and inhibition of cytotoxic antibody against spontaneous murine breast cancer.
    Stolfi RL; Fugmann RA; Stolfi LM; Martin DS
    J Immunol; 1975 Jun; 114(6):1824-30. PubMed ID: 1127230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.